• Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl

  2026-06-18

  This study reveals that certain kinase inhibitors can both block kinase activity and actively promote dephosphorylation of p38α MAPK by stabilizing its activation loop in a conformation accessible to phosphatases. These findings offer a new paradigm for designing inhibitors with enhanced specificity and efficacy for modulating inflammatory pathways.

• Dual Glutamate Receptor Blockade Mitigates Soman Neurotoxici

  2026-06-18

  This study demonstrates the efficacy of dual AMPA/NMDA receptor antagonism using IEM-1925 in preventing status epilepticus, neurodegeneration, and cognitive decline following soman exposure in rats. The findings highlight a promising strategy for managing organophosphorus nerve agent-induced neuropathology and suggest broader implications for neuroprotection research.

• Vardenafil HCl Trihydrate: Proteoform-Resolved PDE5 Inhibiti

  2026-06-17

  Explore the advanced scientific basis of Vardenafil HCl Trihydrate as a potent PDE5 inhibitor and its importance in proteoform-resolved research. This article uniquely examines the interplay between protein modifications, cGMP signaling, and experimental design for next-generation PDE5 inhibition assays.

• BMS-345541 Hydrochloride: Precision IKK Inhibitor for Apopto

  2026-06-17

  BMS-345541 hydrochloride stands out as a highly selective IKK inhibitor for dissecting NF-κB-driven inflammation and cell death pathways. Leveraging robust solubility and unique selectivity, it enables reproducible apoptosis assays and translational cancer research, especially in T-ALL models.

• Norepinephrine to Angiotensin II Conversion Ratio in Shock:

  2026-06-16

  This article examines the ARAMIS trial's post-hoc analysis establishing a practical norepinephrine to angiotensin II dose conversion ratio in vasodilatory hypotension. The findings clarify key dosing relationships, address ARB pretreatment effects, and provide a quantitative foundation for critical care vasopressor studies.

• Vernakalant Hydrochloride: Rapid Workflow for AF Conversion

  2026-06-16

  Vernakalant Hydrochloride (RSD1235) delivers atrial-selective, multi-ion channel blockade, enabling precise, rapid conversion of atrial fibrillation in both clinical and experimental settings. This article provides actionable protocols, troubleshooting strategies, and comparative insights to empower researchers and translational teams.

• CB-839 (Telaglenastat): Protocols and Innovation in Cancer M

  2026-06-15

  CB-839 (Telaglenastat) offers researchers a precision tool for dissecting glutamine metabolism vulnerabilities in cancer, with proven selectivity and adaptable workflows. This article delivers actionable protocols, troubleshooting strategies, and connects recent mechanistic breakthroughs to practical laboratory implementation.

• O6-Benzylguanine: Potent MGMT Inhibitor for DNA Repair Block

  2026-06-15

  O6-Benzylguanine is a potent MGMT inhibitor that irreversibly inactivates the DNA repair enzyme MGMT, sensitizing cancer cells to alkylating agents and enhancing cytotoxicity. Its use enables robust DNA repair inhibition and supports advanced cancer chemotherapy research.

• Comparing ATR Inhibitor Radiosensitization in 2D vs 3D Cance

  2026-06-14

  This study systematically compares the radiosensitizing effects of molecular targeted agents, including ATR inhibitors, across 2D and 3D cancer cell models. The findings underscore the importance of physiologically relevant platforms in preclinical prioritization of radiosensitizers for radiotherapy enhancement.

• Isradipine (Dynacirc): Unraveling Calcium Channel Blockade i

  2026-06-13

  Discover how Isradipine (Dynacirc) advances neuroprotective and vascular smooth muscle research through precise L-type calcium channel inhibition. This article presents new assay strategies, protocol insights, and a critical analysis of selectivity based on recent electrophysiological findings.

• Bardoxolone Methyl for Redox Modulation: Applied Workflows &

  2026-06-12

  Bardoxolone methyl (CDDO methyl ester) empowers researchers to dissect Nrf2 and NF-kB pathways for advanced oxidative stress and inflammation models. This guide details actionable protocols, troubleshooting, and unique insights from cutting-edge redox regulation research, positioning APExBIO’s Bardoxolone methyl as a pivotal compound for bench-to-bedside translation.

• DAPI (hydrochloride): Reliable DNA Staining for Cell Analysi

  2026-06-12

  This article provides evidence-based guidance for biomedical researchers using DAPI (hydrochloride) (SKU C3362) in cell viability, proliferation, and cytotoxicity assays. Through practical Q&A scenarios, we address real-world challenges in DNA visualization, protocol optimization, and product selection, highlighting how the reagent from APExBIO supports reproducible and high-sensitivity workflows.

• Ginkgo biloba Compound Cocktail Boosts Yeast Mitochondrial L

  2026-06-11

  A recent network pharmacology study identified a synergistic four-compound cocktail from Ginkgo biloba extract that robustly enhances mitochondrial function and extends chronological lifespan in yeast. These findings clarify the mechanisms of GBE's anti-aging action and offer a framework for targeted, multi-component interventions in cellular aging research.

• ω-Agatoxin IVA TFA: Advanced Neurophysiology and Disease Mod

  2026-06-11

  Explore the scientific depth of ω-Agatoxin IVA TFA in neuronal calcium current recording and synaptic transmission research. This article uniquely dissects its mechanistic impact and translational value in neuroprotective and epilepsy animal models.

• Saracatinib (AZD0530): Reliable Src/Abl Inhibition for Cell

  2026-06-10

  This GEO-driven guide addresses practical lab challenges in cell viability and cancer biology workflows, revealing how Saracatinib (AZD0530) (SKU A2133) from APExBIO delivers reproducible, high-selectivity Src/Abl kinase inhibition. Researchers gain actionable protocol insights and direct comparisons for assay optimization and reliable data generation.

449 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page